Mycobacterium heckeshornense infection in an immunocompetent patient and identification by 16S rRNA sequence analysis of culture material and a histopathology tissue specimen. by Hest, R. van et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/58701
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
  
10.1128/JCM.42.9.4386-4389.2004. 
2004, 42(9):4386. DOI:J. Clin. Microbiol. 
Lange
Maraha, René van Uffelen, Ronald Schütte and Wiel de
Kremer, Mirjam Dessens, Pieter Westenend, Boulos 
Rob van Hest, Adri van der Zanden, Martin Boeree, Kristin
 
Histopathology Tissue Specimen
Analysis of Culture Material and a 
Identification by 16S rRNA Sequence
in an Immunocompetent Patient and 
 InfectionMycobacterium heckeshornense
http://jcm.asm.org/content/42/9/4386
Updated information and services can be found at: 
These include:
REFERENCES
http://jcm.asm.org/content/42/9/4386#ref-list-1
This article cites 16 articles, 8 of which can be accessed free at:
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 July 9, 2012 by Universiteitsbibliotheek
http://jcm.asm.org/
D
ow
nloaded from
 
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2004, p. 4386–4389 Vol. 42, No. 9
0095-1137/04/$08.000 DOI: 10.1128/JCM.42.9.4386–4389.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Mycobacterium heckeshornense Infection in an Immunocompetent
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Mycobacterium heckeshornense is a rare isolate in clinical specimens. We performed simultaneous 16S rRNA
sequence analysis of a mycobacterium culture and a histopathology specimen to determine the relevance of M.
heckeshornense infection in an immunocompetent patient initially presenting with pneumothorax.
CASE REPORT
In November 2001, a 43-year-old male technical drawer was
admitted to the hospital because of right spontaneous partial
pneumothorax. The medical history revealed left spontaneous
pneumothorax at age 23, followed by left traumatic pneumo-
thorax caused by a fractured-rib puncture after a car accident
3 years later. In January 2001, he suffered from acute inferior
wall myocardial infarction. At that time a chest X-ray (CXR)
showed an area of density in the right upper lobe (RUL) of the
lungs, which was not evaluated further.
After pleural drainage, the right lung expanded completely,
but 8 months later he developed a second pneumothorax at the
right side. He had not complained of prolonged cough or fever
in recent years. He had noticed episodes of night sweats,
weight loss, and fatigue, for which he attended his general
practitioner, who believed the complaints were caused by a
viral infection. Human immunodeficiency virus serology was
negative, and there were no indications of immune deficiency
in his medical history. He had a smoking history of 25 pack
years, i.e., the equivalent of 20 cigarettes/day for 25 years). He
had no history of chronic obstructive pulmonary disease
(COPD). Due to considerable air leakage after pleural drain-
age, a video-assisted thoracoscopy (VATS) with partial pleu-
rectomy and bullectomy was performed. During this proce-
dure, tissue with an abnormal aspect was seen in the apex of
the right lung, and a posterolateral thoracotomy was done to
excise the abnormal tissue.
Histopathological examination of the pleura tissue specimen
recovered by the VATS procedure showed chronic inflamma-
tion and fibrosis and no granulomatous inflammation. Two
lung tissue specimens with maximum diameters of 4 and 4.5 cm
were recovered by the thoracotomy. On macroscopic examina-
tion, both had a granular cut surface, and in one a circum-
scribed brown-gray nodule of approximately 1 cm was seen. On
microscopic examination, this nodule showed extensive necro-
sis with some nuclear dust and anthracosis, no granulocytes,
and a rim of fibrotic tissue containing histiocytic cells and
multinucleated giant cells (Fig. 1). Similar, smaller nodules
were seen in the rest of the tissue. The surrounding lung tissue
showed some fibrosis and chronic inflammation. With fluores-
cence microscopy of auramine-rhodamine-stained slides, nu-
merous small golden-yellow-stained rods were seen. Micro-
scopic examination of Ziehl-Neelsen-stained slides revealed
the same rods but with only faint staining. The histopatholog-
ical finding of a granulomatous inflammation with mycobacte-
ria led to the provisional clinical diagnosis of pulmonary tu-
berculosis.
The tuberculin skin test was negative. In an attempt to ob-
tain bacteriological proof of the diagnosis, fluid from a thora-
cotomy drain was collected. Antituberculous treatment was
started with isoniazid, rifampin, pyrazinamide, and ethambu-
tol. The complaints of intermittent night sweats, weight loss,
and fatigue disappeared. After 2 months, pyrazinamide was
stopped, and the patient continued taking the other drugs,
including ethambutol, since the culture at that time was still
negative.
The direct acid-fast stain of the drain fluid was negative. The
fluid was cultured using two methods: the rapid mycobacte-
rium detection method with liquid mycobacterium growth
indicator tubes (BACTEC MGIT 960; Becton Dickinson,
Alphen aan de Rijn, The Netherlands) and the solid Lo¨wen-
stein-Jensen (LJ) medium. Two months later, the result of the
MGIT culture was negative but the LJ medium showed a few
colonies. A subsequent subculture from the LJ medium be-
came positive 7 weeks later. The acid-fast stain of the isolate
showed acid-fast bacilli. The AccuProbe culture identification
test (Gen-Probe Inc., San Diego, Calif.) for Mycobacterium
tuberculosis complex was negative. The isolate was sent to the
National Institute of Public Health and the Environment
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(RIVM) (Bilthoven, The Netherlands) for species identifica-
tion. At the RIVM, the AccuProbe tests for M. tuberculosis
complex and Mycobacterium avium complex were both nega-
tive. The definite determination was performed by DNA se-
quencing of the species-specific region of the 16S rRNA gene,
as described earlier (6, 9). Comparison with known GenBank
16S rRNA gene sequences revealed Mycobacterium heckeshor-
nense. Drug susceptibility testing showed that the isolate was
susceptible to rifampin, streptomycin, cycloserine, protion-
amide, ciprofloxacin, clofazimin, clarithromycin, and rifabutin,
intermediately sensitive to ethambutol and isoniazid, and re-
sistant to amikacin.
To exclude colonization or instrument contamination during
the VATS procedure, simultaneous 16S rRNA sequence anal-
yses of the culture at the RIVM and of the formalin-fixed
paraffin wax-embedded tissue specimen were performed. Ex-
traction of DNA from the bacterial cells and paraffin wax-
embedded tissues was done as described previously (16). PCR
was performed with two oligonucleotide primers, 16S 8-27 F
(5-AGA GTT TGA TC[AC] TGG CTC AG-3) and 16S myc
300 R (5-GGC CGG ACA CCC TCT C-3). DNA amplifica-
tion was done in 50-l reaction volumes containing 80 pmol of
16S 8-27 F, 40 pmol of 16S myc 300 R, and 25 l of Hot Start
Taq master mix (QIAGEN, Westburg, Leusden, The Nether-
lands). Extracted DNA from the mycobacterium culture (1 l)
and from the sections of the formalin-fixed paraffin wax-em-
bedded tissue (10 l) was added to the tubes, followed by an
overlay of sterile mineral oil (Sigma-Aldrich, St. Louis, Mo.).
The PCR program consisted of 15 min at 95°C followed by a
touchdown of 20 s of denaturation at 95°C, 1 min of annealing,
and 1 min of extension at 72°C. The annealing temperature
was lowered from 66 to 52°C by 1°C per cycle. At 52°C, an
additional 10 cycles were run, and the program ended with
72°C. Purification of the 301-bp PCR product to remove excess
primers and nucleotides was performed with purification col-
umns (QIAGEN). Sequencing was done by using fluorescence-
labeled-dideoxynucleotide technology, using a 3100-Avant se-
quencer (Applied Biosystems, Foster City, Calif.). Sequences
were assembled, edited, and analyzed with the DNAStar pack-
age (Fig. 2). These sequences were deposited in GenBank
(accession number AF174290) and compared with known 16S
rRNA sequences by applying a BLAST search. The DNA
sequences from both strands of the mycobacterium culture and
the histopathology specimen aligned 100% with that of the 16S
rRNA gene of M. heckeshornense.
After 8 months, the simultaneous sequence analyses dem-
onstrated the clinical relevance of the M. heckeshornense in-
fection. Lacking any information on suggested therapy for
M. heckeshornense infection, it was decided that treatment
guidelines for Mycobacterium xenopi infection (10) would be
followed because of the close phylogenetical relationship be-
tween these species. Isoniazid was discontinued, and rifampin
FIG. 1. Lung excision showing granulomatous inflammation: necrosis (right) with a rim of fibrosis containing histiocytes and an occasional
multinucleated giant cell (hematoxylin-eosin staining; original magnification, 100). The inset shows rod-like structures compatible with myco-
bacteria (auramine-rhodamine fluorescence; original magnification, 400).
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and ethambutol were continued for 18 months in total. The
CXRs did not change during treatment.
In 2000, a pathogenic slowly growing scotochromogenic my-
cobacterium species with unique 16S rRNA and 16S-23S spac-
er sequences was reported: M. heckeshornense (13). The novel
Mycobacterium was repeatedly isolated from a 30-year-old im-
munocompetent patient with severe chronic bilateral cavitary
lung disease, and a biopsy of the RUL revealed epithelioid cell
granulomatosis. A second patient, also suffering from progres-
sive cavitary lung disease and histologically confirmed epithe-
lioid cell granuloma, was mentioned later (13a). An identical
Mycobacterium species was already deposited in the GenBank
database with the name “Mycobacterium sydneyiensis” (11). To
our knowledge this is the third patient described with M. hecke-
shornense infection. Furthermore, our patient has an unusual
presentation with pneumothorax.
Our diagnosis of M. heckeshornense as a pathogen meets the
American Thoracic Society diagnostic criteria of nontubercu-
lous mycobacterial lung disease in human immunodeficiency
virus-seronegative hosts, together with the modifications ap-
plied by Jiva and colleagues for clinical relevance of nontuber-
culous mycobacteria (1, 5). A suspicious infiltrate was seen in
the RUL on a previous CXR in a patient with symptoms which
cleared after the start of treatment. The pneumothorax may
have been the result of the mycobacterium infection. A lung
biopsy showed histopathological features of a mycobacterium
infection with granulomatous inflammation and acid-fast ba-
cilli, and a mycobacterial culture on LJ medium from drain
fluid was positive for M. heckeshornense. The possibility of cul-
ture contamination in the present case, especially instrument-
associated pseudoinfection as described for M. xenopi (2, 4,
17), is unlikely, since the amplification and sequencing of the
16S rRNA gene from both the culture isolate and the histo-
pathological specimen were identical.
M. heckeshornense was previously isolated in The Nether-
lands from a 73-year-old patient with COPD after a CXR
showed cavitating opacities in the RUL. Sputa were repeatedly
Ziehl-Neelsen smear positive as well as culture positive on LJ
FIG. 2. Comparison of 16S ribosomal DNA of M. heckeshornense (AF174290), the mycobacterium culture, and the formalin-fixed paraffin
wax-embedded histopathology tissue specimen. Dots indicate identity.
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slants. The AccuProbe test for M. tuberculosis complex was neg-
ative, and determination through 16S sequencing at the RIVM
showed M. heckeshornense. The patient was treated with
isoniazid, rifampin, clarithromycin, and levofloxacin. When
M. heckeshornense was identified shortly afterwards in a 38-
year-old patient in the same regional microbiology laboratory,
this result was considered to be culture contamination and this
patient received no treatment.
M. heckeshornense is phylogenetically closely related to
M. xenopi. M. xenopi is recovered frequently from clinical iso-
lates in southern England and the northwest coast of Europe
but is relatively uncommon elsewhere (2, 12). In immunocom-
petent patients, clinical illness typically occurs as an indolent,
cavitary lung infection in middle-aged men who have other
underlying chronic pulmonary diseases, often COPD (5, 14). It
is thought that reliable separation between M. heckeshornense
and M. xenopi at present can be attained only by 16S rRNA
DNA sequencing (15).
Spontaneous pneumothorax is described as a complication
of pulmonary and miliary tuberculosis (3, 8). Nontuberculous
mycobacterial infection complicated with pneumothorax is less
often reported but was recently described for M. avium infec-
tion (7). Two theories have been postulated for the cause of
pneumothorax in pulmonary tuberculosis: a rupture of the
pleural cavity creates a bronchopleural fistula with spread of
infection to the pleura; a second possible mechanism is the
development of a submucosal bronchiolar lesion with air
trapped in an acinus or subsegment, causing a bleb that can
rupture to the pleural space (R. Belmonte and H. M. Crowe,
Letter, Clin. Infect. Dis. 20:1565, 1995). Although, due to his
medical history, this pneumothorax could be spontaneous, we
assume that the mycobacterial process in the RUL perforated
the pleural cavity.
Finally, 16S rRNA sequence analysis of a formalin-fixed
paraffin wax-embedded histopathology tissue specimen proves
to be a useful tool to determine the clinical significance of a
culture of M. heckeshornense.
We thank Petra de Haas and Dick van Soolingen for valuable com-
ments on an earlier version of the manuscript, Jessica de Beer for
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